Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China

The response rate (defined as the rate of reduction from baseline in the PANSS total score>30%) was also evaluated. The variables with P

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2023-05, Vol.136 (9), p.1126-1128
Main Authors: Li, Qian, Su, Yun’ai, Liao, Xuemei, Fang, Maosheng, Gao, Jianliang, Xu, Jia, Duan, Mingjun, Yu, Haiying, Yang, Yang, Chen, Zhiyu, Liu, Jintong, Yan, Shaoxiao, Yao, Peifen, Li, Shuying, Wang, Changhong, Wu, Bin, Zhang, Congpei, Si, Tianmei
Format: Article
Language:English
Subjects:
Antipsychotic Agents - therapeutic use
Antipsychotics
Aripiprazole - therapeutic use
Benzodiazepines
China
Correspondence
Dopamine
Drug dosages
Humans
Metabolism
Psychotropic drugs
Regression analysis
Response rates
Risperidone
Schizophrenia
Schizophrenia - drug therapy
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The response rate (defined as the rate of reduction from baseline in the PANSS total score>30%) was also evaluated. The variables with P
ISSN:0366-6999
2542-5641
2542-5641
DOI:10.1097/CM9.0000000000002551